Latest in News & Research
Racial Disparity Worsening in Melanoma-Specific Survival
Disparity across minority groups increasing for localized disease; only Hispanics experienced worsening in regional, distant disease
By Dermsquared Editorial Team | | May 26, 2021
Sunscreen Safe, Effective for Reducing Risk for Skin Cancer
Seven consensus statements highlight benefits of sunscreen use for reducing risk for skin cancer; lack of harms to humans
By Dermsquared Editorial Team | | May 26, 2021
Dupilumab Cuts Exacerbations in Children With Asthma
FEV
By Physician’s Briefing Staff | | May 26, 2021
Risk for Autoimmunity Up With Concomitant Vitiligo, Psoriasis
Occurrence of psoriasis was reported before vitiligo in 62.2 percent of patients, especially those with colocalization of lesions
By Physician’s Briefing Staff | | May 26, 2021
Upadacitinib Treats Moderate-to-Severe Atopic Dermatitis
Two replicate double-blind, randomized, placebo-controlled trials show short-term efficacy for upadacitinib in adolescents and adults
By Physician’s Briefing Staff | | May 21, 2021
More Body Surface Area Clearance With Psoriasis Tied to Better Quality of Life
Findings consistent at both six and 12 months of treatment with systemic therapy
By Physician's Briefing Staff | | May 21, 2021
Calcineurin Inhibitors, Phototherapy Do Not Increase Risk for Certain Cancers
No increased risk seen for lymphoma, skin cancer with topical calcineurin inhibitor, phototherapy use for vitiligo
By Dermsquared Editorial Team | | May 19, 2021
Teledermatology Has Good Concordance for Diagnosis, Management
Agreement was almost perfect for imaging decisions and for treatment, but no agreement seen for follow-up planning
By Dermsquared Editorial Team | | May 19, 2021
Internet-Delivered CBT Reduces Atopic Dermatitis Symptoms
Significant reductions also seen in itch intensity, perceived stress, sleep problems, and depression
By Physician's Briefing Staff | | May 19, 2021
Rituximab, Mycophenolate Mofetil Compared for Pemphigus Vulgaris
More patients receiving rituximab versus mycophenolate mofetil had sustained complete remission at week 52, fewer had disease flares
By Physician’s Briefing Staff | | May 19, 2021
Increasing Impact of HPV Vaccination Seen in the United States
Impact on 4vHPV-type prevalence in 2015 to 2018 for 14- to 24-year-old females 90 percent among vaccinated, 74 percent among unvaccinated
By Physician's Briefing Staff | | May 17, 2021
Time, Costs of Participation in MIPS Are Considerable
Mean cost to practices per physician $12,811; 201.7 hours annually spent per physician on MIPS-related activities
By Physician’s Briefing Staff | | May 14, 2021
Baricitinib Shows Long-Term Efficacy for Atopic Dermatitis
Long-term sustained outcomes seen among adults with moderate-to-severe atopic dermatitis
By Physician’s Briefing Staff | | May 13, 2021
Fully Vaccinated Can Shed Masks in Most Outdoor, Indoor Settings: CDC
By Robin Foster and Ernie Mundell (HealthDay News) | | May 13, 2021
Many Current Topical Impetigo Treatments Have Developed Antibiotic Resistance
Topical ozenoxacin may effectively treat impetigo while meeting antibiotic stewardship principles
By Dermsquared Editorial Team | | May 12, 2021
No Increased Risk Found for Soft Tissue Filler Reactions After COVID-19 Vaccine
Delayed inflammatory reactions in soft tissue fillers after COVID-19 vaccine similar to other triggers
By Dermsquared Editorial Team | | May 12, 2021
Hand Dermatitis Currently Prevalent in Health Care Workers
Prevalence of hand dermatitis 92.6 percent in health care workers, 68.7 percent for general population
By Physician's Briefing Staff | | May 12, 2021
Delayed Hypersensitivity Reaction to Moderna COVID-19 Vaccine ID'd
Reaction occurred at or near injection site; reactions were pruritic, painful, and edematous pink plaques
By Physician’s Briefing Staff | | May 12, 2021
Sunburns Severe Enough to Warrant Admission Described
Most patients sustained superficial burns and only 4 percent had full-thickness burns; 19 percent underwent burn wound management surgery
By Physician’s Briefing Staff | | May 12, 2021
FDA Approves Emergency Use of Pfizer Vaccine for Those Aged 12 to 15
By Physician’s Briefing Staff
By Robin Foster and Ernie Mundell (HealthDay News) | | May 11, 2021
Clinical Size of Lentigo Maligna Melanoma Does Not Predict Invasion
However, larger lesions require wider surgical margins
By Dermsquared Editorial Team | | May 05, 2021
Impact of Hidradenitis Suppurativa on Work Productivity Examined
Inguinal/gluteal involvement, severe disease, and higher depression and anxiety scores more common among nonworkers
By Dermsquared Editorial Team | | May 05, 2021
Topical Corticosteroid Use in Pregnancy Not Tied to SGA, LBW
Risks for small for gestational age or low birth weight not increased with exposure to potent or very potent topical corticosteroids
By Physician’s Briefing Staff | | May 05, 2021
24 of 1200